One study reported CD133 expression to be an independent negative prognostic factor in AdCC, significantly associated with larger tumor size, local regional recurrence, distant metastasis, and reduced survival [52], whereas the prognostic significance of this marker was not confirmed in two other studies, including AdCC and/or MEC cases [38,48]. Here, PROM1 is linked to neoplasm.